Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging (Q36103698)

12 August 2017

Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging (English)

1 reference

12 August 2017

1 reference

Sandi A Kwee

1

0 references

author name string

Marc N Coel

series ordinal

2

1 reference

PMC publication ID

3400027

12 August 2017

John Lim

series ordinal

3

1 reference

12 August 2017

2 May 2012

1 reference

Annals of Nuclear Medicine

12 August 2017

1 reference

12 August 2017

26

1 reference

12 August 2017

6

1 reference

12 August 2017

501-507

1 reference

Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Molecular causes of the aberrant choline phospholipid metabolism in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Advances in imaging in the postoperative patient with a rising prostate-specific antigen level

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

Prostate Cancer Working Group Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0601-8

Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400027

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22549847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the clinical outcome after hormonal therapy for prostate cancer between Japanese and Caucasian men

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22549847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Patterns of local failure following prostate brachytherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22549847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12149-012-0601-8

1 reference

12 August 2017

1 reference

PMC publication ID

3400027

12 August 2017

PubMed publication ID

22549847

1 reference

PMC publication ID

3400027